Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

142
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
142
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

123
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
123
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

200
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
200
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

621
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
621
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

487
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
487
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

635
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
635

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Prediction of ICU Mortality in Patients with Acute Hypoxemic Respiratory Failure Using Machine Learning: The MEMORIAL Study.

Journal of clinical medicine·2025
Same author

Extracorporeal CO<sub>2</sub> removal in severe respiratory acidotic intubated patients: A seven year experience observational study.

Respiratory medicine·2025
Same author

Development of a luminescence-based method for measuring West Nile Virus MTase activity and its application to screen for antivirals.

Current research in microbial sciences·2024
Same author

Axion Minicluster Streams in the Solar Neighborhood.

Physical review letters·2024
Same author

Expert perspectives on ECCO<sub>2</sub>R for acute hypoxemic respiratory failure: consensus of a 2022 European roundtable meeting.

Annals of intensive care·2024
Same author

Use of Extracorporeal Carbon Dioxide Removal Therapy in an Intermediate Respiratory Care Unit.

Archivos de bronconeumologia·2024

Related Experiment Video

Updated: Dec 30, 2025

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

1.4K

Continuous hemofiltration in hyperthermic septic shock patients.

David Pestaña1, Elena Casanova, María J Villagrán

  • 1Servicio de Anestesia-Reanimación, Residencia General, Hospital Universitario La Paz, Madrid, Spain. dpestana.hulp@salud.madrid.org

The Journal of Trauma
|December 20, 2007
PubMed
Summary

Treating severe hyperthermia in septic shock patients with continuous hemofiltration significantly reduced mortality. This intervention lowered body temperature and decreased the need for vasopressors, offering a promising approach for critical care.

More Related Videos

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
07:51

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs

Published on: May 21, 2019

7.7K
Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

24.9K

Related Experiment Videos

Last Updated: Dec 30, 2025

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

1.4K
Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
07:51

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs

Published on: May 21, 2019

7.7K
Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

24.9K

Area of Science:

  • Critical Care Medicine
  • Nephrology
  • Infectious Diseases

Background:

  • Severe hyperthermia is common in septic shock and associated with high mortality.
  • Sustained fever, even without infection, can activate inflammatory responses.
  • A protocol was developed to decrease hyperthermia using hemofiltration in patients unresponsive to antipyretics.

Purpose of the Study:

  • To evaluate the efficacy of hemofiltration in managing hyperthermia in septic shock.
  • To assess the impact of temperature reduction on hemodynamic parameters and mortality.
  • To compare outcomes with a historical control group.

Main Methods:

  • 19 hyperthermic septic shock patients with multi-organ failure were treated with continuous low-flow hemofiltration or hemodiafiltration.
  • Core body temperature was monitored hourly.
  • A hemodynamic index (HI) was calculated using mean arterial pressure and noradrenaline dose.

Main Results:

  • Hemofiltration significantly decreased core body temperature from 39.8°C to 37°C within 24 hours (p < 0.001).
  • The hemodynamic index showed significant improvement after 24 hours of treatment (p = 0.008).
  • Twenty-eight-day mortality was 32% in the hemofiltration group versus 100% in the historical control group (p < 0.001).

Conclusions:

  • Continuous low-flow hemofiltration effectively reduces body temperature in hyperthermic septic shock.
  • This method also decreases vasopressor requirements in affected patients.
  • The study observed a significantly lower mortality rate, suggesting hemofiltration as a beneficial therapeutic strategy.